# Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI

Study · id `cardio:ct-nct03001960` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03001960](<https://clinicaltrials.gov/study/NCT03001960>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03001960

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT03001960. Randomized; double masking; primary purpose treatment. Start 2017-03 (registry gives no type); primary completion 2018-03 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT03001960, source copy `cardio:ctgov-nct03001960-2016-12-28`, retrieved 2026-10-26)
- Start date: 2017-03 (registry gives no type) (ClinicalTrials.gov record NCT03001960, source copy `cardio:ctgov-nct03001960-2016-12-28`, retrieved 2026-10-26)
- Primary completion: 2018-03 (anticipated) (ClinicalTrials.gov record NCT03001960, source copy `cardio:ctgov-nct03001960-2016-12-28`, retrieved 2026-10-26)
- Completion: 2018-04 (anticipated) (ClinicalTrials.gov record NCT03001960, source copy `cardio:ctgov-nct03001960-2016-12-28`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03001960-2016-12-28`, retrieved 2026-10-26)

## The registry's words

- Brief title: Dual AntiPlatelet Therapies for Prevention of Periinterventional Embolic Events in TAVI
- Acronym: DAPT-TAVI
- Condition: Aortic Valve Stenosis
- Condition: Transcatheter Aortic Valve Replacement
- Condition: Intracranial Embolism
- Intervention (Drug): Preloading before TAVI
- Intervention (Drug): Postloading after TAVI
- Lead sponsor: Charite University, Berlin, Germany
- Lead sponsor class: OTHER
- Collaborator: Prof. Dr. Jochen Fiebach, Center for Stroke Research Berlin (CSB), Charité - Universitaetsmedizin Berlin
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Charite University, Berlin, Germany (`cardio:org-charite-university-berlin-germany`)

## Provenance

Content hash: 83f23e36c017f098ba704dec8e0405e5364574643ca255ccb08a738fae2c31c9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
